Breanna Caruso, Benjamin R Weeder, Reid F Thompson, Amy E Moran
{"title":"PD-1 限制 IL-2 的产生和胸腺调节性 T 细胞的发育","authors":"Breanna Caruso, Benjamin R Weeder, Reid F Thompson, Amy E Moran","doi":"10.4049/immunohorizons.2300079","DOIUrl":null,"url":null,"abstract":"<p><p>Inhibitory proteins, such as programmed cell death protein 1 (PD-1), have been studied extensively in peripheral T cell responses to foreign Ags, self-Ags, and neoantigens. Notably, these proteins are first expressed during T cell development in the thymus. Reports suggest that PD-1 limits regulatory T cell (Treg) development, but the mechanism by which PD-1 exerts this function remains unknown. The present study expands the evaluation of murine PD-1 and its ligands in the thymus, demonstrating that some of the highest expressers of PD-1 and programmed death-ligand 1 are agonist selected cells. Surprisingly, we reveal a selective role for PD-1 in regulating the developmental niche only for Tregs because other agonist selected cell populations, such as NK T cells, remain unchanged. We also ruled out PD-1 as a regulator of proliferation or cell death of agonist selected Tregs and further demonstrated that PD-1-deficient Tregs have reduced TCR signaling. Unexpectedly, the data suggest that PD-1-deficient thymocytes produce elevated levels of IL-2, a Treg niche-limiting cytokine. Collectively, these data suggest a novel role for PD-1 in regulating IL-2 production and the concurrent agonist selection of murine thymic Tregs. This observation has implications for the use of checkpoint blockade in the context of cancer and infection.</p>","PeriodicalId":94037,"journal":{"name":"ImmunoHorizons","volume":"8 3","pages":"281-294"},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10985057/pdf/","citationCount":"0","resultStr":"{\"title\":\"PD-1 Limits IL-2 Production and Thymic Regulatory T Cell Development.\",\"authors\":\"Breanna Caruso, Benjamin R Weeder, Reid F Thompson, Amy E Moran\",\"doi\":\"10.4049/immunohorizons.2300079\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Inhibitory proteins, such as programmed cell death protein 1 (PD-1), have been studied extensively in peripheral T cell responses to foreign Ags, self-Ags, and neoantigens. Notably, these proteins are first expressed during T cell development in the thymus. Reports suggest that PD-1 limits regulatory T cell (Treg) development, but the mechanism by which PD-1 exerts this function remains unknown. The present study expands the evaluation of murine PD-1 and its ligands in the thymus, demonstrating that some of the highest expressers of PD-1 and programmed death-ligand 1 are agonist selected cells. Surprisingly, we reveal a selective role for PD-1 in regulating the developmental niche only for Tregs because other agonist selected cell populations, such as NK T cells, remain unchanged. We also ruled out PD-1 as a regulator of proliferation or cell death of agonist selected Tregs and further demonstrated that PD-1-deficient Tregs have reduced TCR signaling. Unexpectedly, the data suggest that PD-1-deficient thymocytes produce elevated levels of IL-2, a Treg niche-limiting cytokine. Collectively, these data suggest a novel role for PD-1 in regulating IL-2 production and the concurrent agonist selection of murine thymic Tregs. This observation has implications for the use of checkpoint blockade in the context of cancer and infection.</p>\",\"PeriodicalId\":94037,\"journal\":{\"name\":\"ImmunoHorizons\",\"volume\":\"8 3\",\"pages\":\"281-294\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10985057/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ImmunoHorizons\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4049/immunohorizons.2300079\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ImmunoHorizons","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4049/immunohorizons.2300079","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
在外周 T 细胞对外来抗原、自身抗原和新抗原的反应中,对抑制蛋白(如程序性细胞死亡蛋白 1 (PD-1))进行了广泛的研究。值得注意的是,这些蛋白最初是在胸腺中的 T 细胞发育过程中表达的。有报告表明,PD-1 限制了调节性 T 细胞(Treg)的发育,但 PD-1 发挥这一功能的机制仍不清楚。本研究扩大了对小鼠胸腺中 PD-1 及其配体的评估,证明 PD-1 和程序性死亡配体 1 的一些最高表达者是经过激动剂选择的细胞。令人惊讶的是,我们揭示了 PD-1 在调节发育龛位方面只对 Tregs 起选择性作用,因为其他激动剂选择细胞群(如 NK T 细胞)保持不变。我们还排除了 PD-1 作为激动剂选择的 Treg 增殖或细胞死亡调节因子的可能性,并进一步证明了 PD-1 缺失的 Treg 的 TCR 信号传导能力降低。意想不到的是,数据表明 PD-1 缺陷胸腺细胞产生的 IL-2 水平升高,而 IL-2 是一种 Treg 龛限制细胞因子。总之,这些数据表明 PD-1 在调节 IL-2 的产生和小鼠胸腺 Tregs 的同步激动剂选择方面发挥了新的作用。这一观察结果对在癌症和感染背景下使用检查点阻断疗法具有重要意义。
PD-1 Limits IL-2 Production and Thymic Regulatory T Cell Development.
Inhibitory proteins, such as programmed cell death protein 1 (PD-1), have been studied extensively in peripheral T cell responses to foreign Ags, self-Ags, and neoantigens. Notably, these proteins are first expressed during T cell development in the thymus. Reports suggest that PD-1 limits regulatory T cell (Treg) development, but the mechanism by which PD-1 exerts this function remains unknown. The present study expands the evaluation of murine PD-1 and its ligands in the thymus, demonstrating that some of the highest expressers of PD-1 and programmed death-ligand 1 are agonist selected cells. Surprisingly, we reveal a selective role for PD-1 in regulating the developmental niche only for Tregs because other agonist selected cell populations, such as NK T cells, remain unchanged. We also ruled out PD-1 as a regulator of proliferation or cell death of agonist selected Tregs and further demonstrated that PD-1-deficient Tregs have reduced TCR signaling. Unexpectedly, the data suggest that PD-1-deficient thymocytes produce elevated levels of IL-2, a Treg niche-limiting cytokine. Collectively, these data suggest a novel role for PD-1 in regulating IL-2 production and the concurrent agonist selection of murine thymic Tregs. This observation has implications for the use of checkpoint blockade in the context of cancer and infection.